Education will help address memory care supplement issues: GAO
By
Lois A. Bowers
Jun 15, 2017
Do you know of any senior living residents taking supplements believing that they will prevent memory-related diseases? If so, a new report from the Government Accountability Office suggests that they...
More news for Thursday, April 13
Apr 12, 2017
This is what retirement looked like in 1970 … BOKF seeks dismissal of class action suit over Brogdon-related bonds … Focus on Alzheimer’s disease shifts to prevention … Independent...
More news for Wednesday, Dec. 21
Dec 20, 2016
Ohio makes assisted suicide a felony … How a senior living chef bridges generational taste gaps … Landmark Alzheimer’s prevention trial to evaluate third drug … Pokemon GO got people...
More news for Friday, Dec. 2
Dec 01, 2016
Retail giant to expand overtime pay despite temporary injunction … Senator accuses GOP of “war on seniors” … House overwhelmingly approves sweeping health measure … iPhones...
Alzheimer’s research would get $1.26 billion under House bill
By
Lois A. Bowers
Jul 07, 2016
The federal government would receive $1.26 billion for Alzheimer’s research under a Labor, Health and Human Services Subcommittee funding bill put forth this week for fiscal year 2017.
Step up efforts to combat Alzheimer’s disease, experts urge
By
John O'Connor
May 29, 2018
Expanded efforts to understand and treat Alzheimer’s disease will be essential to unlocking its cure, according to experts at a national summit.
New Alzheimer’s definition will ‘dramatically’ increase those thought to have disease
By
Lois A. Bowers
Apr 11, 2018
A proposed new definition of Alzheimer’s disease unveiled Tuesday represents “a major evolution in how we think about Alzheimer’s,” according to the Alzheimer’s Association,...
Alzheimer’s test can diagnose disease decades before symptoms appear
Nov 09, 2015
A test leading to the diagnosis of Alzheimer’s disease 10 to 30 years before symptoms appear has been formally classified as the international reference method, which means that it will be used as...
AAN issues review of evidence for aducanumab in Alzheimer’s disease
Mar 03, 2022
A class I study shows that single doses of aducanumab are safe and well-tolerated; class II studies show reduced amyloid deposition on brain PET at one year.
Modern technology’s positive effects on memory care
By
Tom Rotz
Apr 18, 2016
Advancements in technology can have a positive effect on memory care and those affected, by improving quality of life and even slowing the progression of the disease.